Table 1.
Patient demographics and characteristics at baseline
| Characteristic | N = 17 |
|---|---|
| Median age (range) – year | 49 (20–80) |
| Gender - no. (%) | |
| Male | 6 (35.3) |
| Female | 11 (64.7) |
| Race - no. (%) | |
| White non-Hispanic | 15 (88.2) |
| Other | 2 (11.8) |
| ECOG performance status - no. (%) | |
| 0 | 10 (58.8) |
| 1 | 7 (41.2) |
| Primary tumor - no. (%) | |
| Neurofibromatosis type 2 | 5 (29.4) |
| Urothelial carcinoma | 3 (17.6) |
| Carcinoma of unknown primarya | 2 (11.8) |
| Breast | 2 (11.8) |
| Meningioma | 2 (11.8) |
| Small cell lung cancer | 1 (5.9) |
| Sertoli cell carcinoma of testis | 1 (5.9) |
| Uveal melanoma | 1 (5.9) |
| Prior lines of systemic therapy - no. (%) | |
| 0 | 5 (29.4) |
| 1–2 | 5 (29.4) |
| 3 | 7 (41.2) |
a
One likely urothelial carcinoma, one likely pancreaticobiliary